Why the study?
Does umbilical vein adenosine infusion via cordocentesis aid in the differential diagnosis of fetal tachyarrhythmia with 1:1 AV conduction to guide antiarrhythmic therapy?
Case Report (n=1)
No
Does umbilical vein adenosine infusion via cordocentesis aid in the differential diagnosis of fetal tachyarrhythmia with 1:1 AV conduction to guide antiarrhythmic therapy?
Adenosine administration via cordocentesis can safely induce transient AV block to differentiate fetal 1:1 atrial flutter from nodal-dependent supraventricular tachycardia, guiding effective targeted antiarrhythmic therapy in hydropic fetuses.
Answers are grounded in this paper and cite their sources.
Supports diagnostic adenosine via cordocentesis in fetal tachyarrhythmia; leaves open prospective validation before clinical adoption.
This is the report of a case of fetal tachyarrhythmia with 1:1 atrioventricular conduction detected by pre-natal echocardiography in a fetus at 25-weeks gestation. Adenosine infusion via cordocentesis was performed as a diagnostic test to differentiate between atrioventricular nodal reentrant supraventricular tachyarrhythmia and atrial flutter. After infusion, transient 2:1 atrioventricular dissociation was obtained and the diagnosis of atrial flutter was made. Transplacental therapy with digoxin and amiodarone was then successfully used.
No takes yet. Share an insight, caveat, or question.
Leiria et al. (2000) conducted a case report in Fetal tachyarrhythmia with 1:1 atrioventricular conduction and fetal hydrops (n=1). Adenosine infusion via cordocentesis followed by cordocentesis and transplacental amiodarone and digoxin was evaluated on Differential diagnosis of tachyarrhythmia and restoration of sinus rhythm with resolution of fetal hydrops.
Synapse has enriched 10 related papers. Consider them for comparative context: